GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NextGen Biomed Ltd (XTAE:NXGN) » Definitions » Shares Buyback Ratio %

NextGen Biomed (XTAE:NXGN) Shares Buyback Ratio % : -9.84 (As of Jun. 07, 2024)


View and export this data going back to 2000. Start your Free Trial

What is NextGen Biomed Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. NextGen Biomed's current shares buyback ratio was -9.84%.

NextGen Biomed Shares Buyback Ratio % Historical Data

The historical data trend for NextGen Biomed's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextGen Biomed Shares Buyback Ratio % Chart

NextGen Biomed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only - - - -36.84 -9.25

NextGen Biomed Semi-Annual Data
Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -36.84 - -9.25 -0.53

NextGen Biomed Shares Buyback Ratio % Calculation

NextGen Biomed's Shares Buyback Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2021 ) - Shares Outstanding (EOP) (A: Dec. 2022 )) / Shares Outstanding (EOP) (A: Dec. 2021 )
=(6.61275 - 7.22476) / 6.61275
=-9.25%

NextGen Biomed's Shares Buyback Ratio for the quarter that ended in Jun. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2022 ) - Shares Outstanding (EOP) (A: Jun. 2023 )) / Shares Outstanding (EOP) (A: Dec. 2022 )
=(7.22476 - 7.26338) / 7.22476
=-0.53%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NextGen Biomed Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of NextGen Biomed's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

NextGen Biomed (XTAE:NXGN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NextGen Biomed Ltd (XTAE:NXGN) » Definitions » Shares Buyback Ratio %
Comparable Companies
XTAE:STRG ISRG XPAR:EL BDX XSWX:ALC TSE:7741 WST OCSE:COLO B RMD TSE:4543 XSWX:STMN BAX XPAR:DIM HOLX TSE:7733 COO TSE:6869 SZSE:300896 TFX STVN
Traded in Other Exchanges
N/A
Address
Azrieli Center, Round Tower 22nd Floor, Tel Aviv, ISR, 6701101
Website
http://www.nextgen-biomed.com
NextGen Biomed Ltd is pharmaceutical company. It manufactures medical instruments. Its products include pain-free auto-injectors, lancet devices and personal use pain alleviators. It develops and markets medical equipments. Its product line include DPS-101, which is used for treatment for psoriasis. Its other product line include DPS-101 phase II/III is in clinical trial.